Organization
CARA Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
CARA Therapeutics, Inc.
... and shareholders of TrustCo Bank Corp NY (NASDAQ:TRST), Actua Corporation (NASDAQ:ACTA), Cara Therapeutics, Inc. (NASDAQ:CARA), Cabot Oil & Gas Corporation (NYSE:COG), Astronics Corporation (NASDAQ:ATRO), and ...
... This NDA has been accepted by the FDA for Priority Review. Cara Therapeutics Inc(NASDAQ: CARA) is a clinical-stage biopharmaceutical company focused on developing and commercializing ...
... in what is projected to be a $7 billion state-wide market." Cara Therapeutics,Inc.(NASDAQ: CARA) is a clinical-stage biopharmaceutical company focused on developing and commercializing new ...
... all internet traffic at peak hours. Included in today's commentary: Cara Therapeutics Inc (NASDAQ: CARA), Insys Therapeutics (NASDAQ: INSY), Terra Tech Corp (OTC: TRTC), Innovative ...
... GWPH),Zynerba Pharmaceuticals, Inc.(NASDAQ: ZYNE), ) andIsodiol International Inc.(CSE: ISOL) (OTC: ISOLF). Cara Therapeutics, Inc.(NASDAQ: CARA Backed by mounting scientific data on the curative effects of ...
... Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), GW Pharmaceuticals plc (NASDAQ: GWPH), Cara Therapeutics Inc. (NASDAQ: CARA) Growth of the medical cannabis market is expected to quicken ...
... Aurinia Pharmaceuticals Inc., Axovant Sciences Ltd., Bioverativ Inc., Calithera Biosciences, Inc., Cara Therapeutics Inc., Cascadian Therapeutics, Inc., Cellectis SA, Calyxt, Inc., Chimerix, Inc., Concert Pharmaceuticals ...
... others in the biotech space, such asGW Pharmaceuticals (NASDAQ: GWPH),Zynerba Pharmaceuticals(NASDAQ: ZYNE),Cara Therapeutics, Inc.(NASDAQ: CARA) andAxim Biotechnologies(OTC: AXIM). While most cannabis-focused biotechs funnel their resources ...
... cannabinoid medicines and drug classes includeGW Pharmaceuticals(NASDAQ: GWPH), Zynerba Pharmaceuticals(NASDAQ: ZYNE), Cara Therapeutics, Inc.(NASDAQ: CARA) andAxim Biotechnologies(OTC: AXIM). Other biopharmaceutical companies may produce cannabinoids in ...
... Pharmaceuticals plc (NASDAQ: GWPH), 22nd Century Group Inc. (NYSE: XXII), Cara Therapeutics Inc. (NASDAQ: CARA), Cannabis Sativa, Inc. (OTC: CBDS) Giadha Aguirre De Carcer, CEO ...
... Inc. (CSE: VRT) (OTC: VRTHF), Perrigo Company plc (NYSE: PRGO). Cara Therapeutics, Inc. (NASDAQ: CARA), Trevena, Inc. (NASDAQ: TRVN), Collegium Pharmaceutical, Inc. http://www.marketnewsupdates.com/news/vrt.html Veritas Pharma ...
... important innovations in this industry, includingGW Pharmaceuticals plc(NASDAQ: GWPH),Zynerba Pharmaceuticals, Inc.(NASDAQ: ZYNE),Cara Therapeutics, Inc.(NASDAQ: CARA) andINSYS Therapeutics, Inc.(NASDAQ: INSY). Extracting cannabinoids for medicinal applications using ...
... STAMFORD - Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new ...
... Pharmaceutical, Inc. (NASDAQ: COLL), Perrigo Company plc (NYSE: PRGO) and Cara Therapeutics, Inc. (NASDAQ: CARA). Therapix Biosciences Ltd.(NASDAQ: TRPX), Therapix Biosciences Ltd. (NASDAQ: TRPX), a ...
... STAMFORD, Conn., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical ...
... OncoSec Medical Incorporated (NASDAQ: ONCS), TherapeuticsMD Inc. (NASDAQ: TXMD) and Cara Therapeutics Inc. (NASDAQ: CARA). Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Breaking News:International Study atMD AndersonSister ...
... If you want a Stock Review on CARA, CATB, CERS, or GNCA then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... STAMFORD, Conn. - Cara Therapeutics, Inc. (Nasdaq: CARA), a biotechnology company focused on developing and commercializing new chemical ...
... Zynerba Pharmaceuticals (NASDAQ: ZYNE), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), Cara Therapeutics Inc (NASDAQ: CARA), Cannabis Sativa, Inc. (OTC: CBDS) A research report published by ...
... STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a loss of $12.4 million in its ...
... STAMFORD, Conn., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a biotechnology company focused on developing and commercializing new chemical ...
... developing innovative drug products built around its proprietary delivery technologies, congratulates Cara Therapeutics (Nasdaq: CARA) on the successful initiation of its Phase 1 clinical trial ...
... STAMFORD, Conn., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical ...
... STAMFORD, Conn., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical ...
Want to see the full history on CARA Therapeutics, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial